INCYTE CORPORATION Earnings Per Share (Diluted)
INCYTE CORPORATION (INCY) reported Earnings Per Share (Diluted) of $1.47 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-04-28
- INCYTE CORPORATION earnings per share, diluted for the quarter ending 2026-03-31 was $1.47, a 83.75% increase year-over-year.
- INCYTE CORPORATION earnings per share, diluted for the quarter ending 2025-12-31 was $1.46, a 50.37% increase year-over-year.
- INCYTE CORPORATION earnings per share, diluted for the quarter ending 2025-09-30 was $2.11, a 290.74% increase year-over-year.
- INCYTE CORPORATION earnings per share, diluted for the quarter ending 2025-06-30 was $2.04.
- INCYTE CORPORATION earnings per share, diluted for fiscal 2025 was $6.41, a 4173.33% increase from fiscal 2024.
- INCYTE CORPORATION earnings per share, diluted for fiscal 2024 was $0.15, a 94.34% decline from fiscal 2023.
- INCYTE CORPORATION earnings per share, diluted for fiscal 2023 was $2.65, a 74.34% increase from fiscal 2022.
- INCYTE CORPORATION earnings per share, diluted for fiscal 2022 was $1.52, a 64.40% decline from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-03-31 | $1.47 10-Q · filed 2026-04-28 | $2.93 derived: net income ÷ weighted average shares · filed 2026-04-28 | $5.03 derived: net income ÷ weighted average shares · filed 2026-04-28 | $7.06 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2025-12-31 | $1.46 derived: net income ÷ weighted average shares · filed 2026-02-10 | $3.56 derived: net income ÷ weighted average shares · filed 2026-02-10 | $5.60 derived: net income ÷ weighted average shares · filed 2026-02-10 | $6.41 10-K · filed 2026-02-10 |
| 2025-09-30 | $2.11 10-Q · filed 2025-10-28 | $4.14 derived: net income ÷ weighted average shares · filed 2025-10-28 | $4.95 10-Q · filed 2025-10-28 | $5.90 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2025-06-30 | $2.04 10-Q · filed 2025-07-29 | $2.84 10-Q · filed 2025-07-29 | $3.80 derived: net income ÷ weighted average shares · filed 2026-04-28 | $4.36 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2025-03-31 | $0.80 10-Q · filed 2026-04-28 | $1.77 derived: net income ÷ weighted average shares · filed 2026-04-28 | $2.33 derived: net income ÷ weighted average shares · filed 2026-04-28 | $0.10 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2024-12-31 | $0.97 derived: net income ÷ weighted average shares · filed 2026-02-10 | $1.53 derived: net income ÷ weighted average shares · filed 2026-02-10 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-02-10 | $0.15 10-K · filed 2026-02-10 |
| 2024-09-30 | $0.54 10-Q · filed 2025-10-28 | -$1.63 derived: net income ÷ weighted average shares · filed 2025-10-28 | -$0.80 10-Q · filed 2025-10-28 | $0.15 derived: net income ÷ weighted average shares · filed 2026-02-10 |
| 2024-06-30 | -$2.04 10-Q · filed 2025-07-29 | -$1.24 10-Q · filed 2025-07-29 | -$0.33 derived: net income ÷ weighted average shares · filed 2026-02-10 | $0.43 derived: net income ÷ weighted average shares · filed 2026-02-10 |
| 2024-03-31 | $0.75 10-Q · filed 2025-04-29 | $1.63 derived: net income ÷ weighted average shares · filed 2026-02-10 | $2.39 derived: net income ÷ weighted average shares · filed 2026-02-10 | $3.29 derived: net income ÷ weighted average shares · filed 2026-02-10 |
| 2023-12-31 | $0.89 derived: net income ÷ weighted average shares · filed 2026-02-10 | $1.65 derived: net income ÷ weighted average shares · filed 2026-02-10 | $2.55 derived: net income ÷ weighted average shares · filed 2026-02-10 | $2.65 10-K · filed 2026-02-10 |
| 2023-09-30 | $0.76 10-Q · filed 2024-10-29 | $1.66 derived: net income ÷ weighted average shares · filed 2024-10-29 | $1.76 10-Q · filed 2024-10-29 | $1.88 derived: net income ÷ weighted average shares · filed 2025-02-10 |
| 2023-06-30 | $0.90 10-Q · filed 2024-07-30 | $1.00 10-Q · filed 2024-07-30 | $1.13 derived: net income ÷ weighted average shares · filed 2025-02-10 | $1.63 derived: net income ÷ weighted average shares · filed 2025-02-10 |
| 2023-03-31 | $0.10 10-Q · filed 2024-04-30 | $0.22 derived: net income ÷ weighted average shares · filed 2025-02-10 | $0.72 derived: net income ÷ weighted average shares · filed 2025-02-10 | $1.44 derived: net income ÷ weighted average shares · filed 2025-02-10 |
| 2022-12-31 | $0.13 derived: net income ÷ weighted average shares · filed 2025-02-10 | $0.63 derived: net income ÷ weighted average shares · filed 2025-02-10 | $1.35 derived: net income ÷ weighted average shares · filed 2025-02-10 | $1.52 10-K · filed 2025-02-10 |
| 2022-09-30 | $0.50 10-Q · filed 2023-10-31 | $1.22 derived: net income ÷ weighted average shares · filed 2023-10-31 | $1.40 10-Q · filed 2023-10-31 | $3.93 derived: net income ÷ weighted average shares · filed 2024-02-13 |
| 2022-06-30 | $0.72 10-Q · filed 2023-08-01 | $0.89 10-Q · filed 2023-08-01 | $3.42 derived: net income ÷ weighted average shares · filed 2024-02-13 | $4.24 derived: net income ÷ weighted average shares · filed 2024-02-13 |
| 2022-03-31 | $0.17 10-Q · filed 2023-05-02 | $2.71 derived: net income ÷ weighted average shares · filed 2024-02-13 | $3.52 derived: net income ÷ weighted average shares · filed 2024-02-13 | $4.20 derived: net income ÷ weighted average shares · filed 2024-02-13 |
| 2021-12-31 | $2.54 derived: net income ÷ weighted average shares · filed 2024-02-13 | $3.36 derived: net income ÷ weighted average shares · filed 2024-02-13 | $4.03 derived: net income ÷ weighted average shares · filed 2024-02-13 | $4.27 10-K · filed 2024-02-13 |
| 2021-09-30 | $0.82 10-Q · filed 2022-11-01 | $1.49 derived: net income ÷ weighted average shares · filed 2022-11-01 | $1.73 10-Q · filed 2022-11-01 | $2.41 derived: net income ÷ weighted average shares · filed 2023-02-07 |
| 2021-06-30 | $0.67 10-Q · filed 2022-08-02 | $0.91 10-Q · filed 2022-08-02 | $1.59 derived: net income ÷ weighted average shares · filed 2023-02-07 | $1.53 derived: net income ÷ weighted average shares · filed 2023-02-07 |
| 2021-03-31 | $0.24 10-Q · filed 2022-05-03 | $0.92 derived: net income ÷ weighted average shares · filed 2023-02-07 | $0.85 derived: net income ÷ weighted average shares · filed 2023-02-07 | $2.17 derived: net income ÷ weighted average shares · filed 2023-02-07 |
| 2020-12-31 | $0.68 10-K · filed 2021-02-09 | $0.61 derived: net income ÷ weighted average shares · filed 2023-02-07 | $1.93 derived: net income ÷ weighted average shares · filed 2023-02-07 | -$1.36 10-K · filed 2023-02-07 |
| 2020-09-30 | -$0.07 10-Q · filed 2021-11-02 | $1.25 derived: net income ÷ weighted average shares · filed 2021-11-02 | -$2.05 10-Q · filed 2021-11-02 | -$1.53 derived: net income ÷ weighted average shares · filed 2022-02-08 |
| 2020-06-30 | $1.32 10-Q · filed 2021-08-03 | -$1.98 10-Q · filed 2021-08-03 | -$1.46 derived: net income ÷ weighted average shares · filed 2022-02-08 | -$0.87 derived: net income ÷ weighted average shares · filed 2022-02-08 |
| 2020-03-31 | -$3.33 10-Q · filed 2021-05-04 | -$2.80 derived: net income ÷ weighted average shares · filed 2022-02-08 | -$2.21 derived: net income ÷ weighted average shares · filed 2022-02-08 | -$1.73 derived: net income ÷ weighted average shares · filed 2022-02-08 |
| 2019-12-31 | $0.51 10-K · filed 2021-02-09 | $1.10 derived: net income ÷ weighted average shares · filed 2022-02-08 | $1.58 derived: net income ÷ weighted average shares · filed 2022-02-08 | $2.05 10-K · filed 2022-02-08 |
| 2019-09-30 | $0.59 10-K · filed 2021-02-09 | $1.07 derived: net income ÷ weighted average shares · filed 2021-02-09 | $1.55 10-Q · filed 2020-11-05 | $1.87 derived: net income ÷ weighted average shares · filed 2021-02-09 |
| 2019-06-30 | $0.48 10-K · filed 2021-02-09 | $0.96 10-Q · filed 2020-08-04 | $1.28 derived: net income ÷ weighted average shares · filed 2021-02-09 | $1.41 derived: net income ÷ weighted average shares · filed 2021-02-09 |
| 2019-03-31 | $0.47 10-K · filed 2021-02-09 | $0.79 derived: net income ÷ weighted average shares · filed 2021-02-09 | $0.93 derived: net income ÷ weighted average shares · filed 2021-02-09 | $1.17 derived: net income ÷ weighted average shares · filed 2021-02-09 |
| 2018-12-31 | $0.32 10-K · filed 2020-02-13 | $0.45 derived: net income ÷ weighted average shares · filed 2021-02-09 | $0.70 derived: net income ÷ weighted average shares · filed 2021-02-09 | $0.51 10-K · filed 2021-02-09 |
| 2018-09-30 | $0.14 10-K · filed 2020-02-13 | $0.38 derived: net income ÷ weighted average shares · filed 2020-02-13 | $0.19 10-Q · filed 2019-10-29 | -$0.51 derived: net income ÷ weighted average shares · filed 2020-02-13 |
| 2018-06-30 | $0.24 10-K · filed 2020-02-13 | $0.05 10-Q · filed 2019-07-30 | -$0.65 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$0.48 derived: net income ÷ weighted average shares · filed 2020-02-13 |
| 2018-03-31 | -$0.19 10-K · filed 2020-02-13 | -$0.90 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$0.73 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$0.80 derived: net income ÷ weighted average shares · filed 2020-02-13 |
| 2017-12-31 | -$0.71 10-K · filed 2019-02-14 | -$0.54 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$0.60 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$1.53 10-K · filed 2020-02-13 |
| 2017-09-30 | $0.17 10-K · filed 2019-02-14 | $0.11 derived: net income ÷ weighted average shares · filed 2019-02-14 | -$0.81 10-Q · filed 2018-10-30 | -$0.77 derived: net income ÷ weighted average shares · filed 2019-02-14 |
| 2017-06-30 | -$0.06 10-K · filed 2019-02-14 | -$1.00 10-Q · filed 2018-07-31 | -$0.96 derived: net income ÷ weighted average shares · filed 2019-02-14 | -$0.78 derived: net income ÷ weighted average shares · filed 2019-02-14 |
| 2017-03-31 | -$0.96 10-K · filed 2019-02-14 | -$0.91 derived: net income ÷ weighted average shares · filed 2019-02-14 | -$0.73 derived: net income ÷ weighted average shares · filed 2019-02-14 | -$0.55 derived: net income ÷ weighted average shares · filed 2019-02-14 |
| 2016-12-31 | $0.05 10-K · filed 2018-02-15 | $0.23 derived: net income ÷ weighted average shares · filed 2019-02-14 | $0.41 derived: net income ÷ weighted average shares · filed 2019-02-14 | $0.54 10-K · filed 2019-02-14 |
| 2016-09-30 | $0.19 10-K · filed 2018-02-15 | $0.37 derived: net income ÷ weighted average shares · filed 2018-02-15 | $0.49 10-Q · filed 2017-10-31 | $0.78 derived: net income ÷ weighted average shares · filed 2018-02-15 |
| 2016-06-30 | $0.18 10-K · filed 2018-02-15 | $0.30 10-Q · filed 2017-08-01 | $0.59 derived: net income ÷ weighted average shares · filed 2018-02-15 | $0.39 derived: net income ÷ weighted average shares · filed 2018-02-15 |
| 2016-03-31 | $0.12 10-K · filed 2018-02-15 | $0.41 derived: net income ÷ weighted average shares · filed 2018-02-15 | $0.21 derived: net income ÷ weighted average shares · filed 2018-02-15 | $0.26 derived: net income ÷ weighted average shares · filed 2018-02-15 |
| 2015-12-31 | $0.29 10-K · filed 2017-02-14 | $0.08 derived: net income ÷ weighted average shares · filed 2018-02-15 | $0.13 derived: net income ÷ weighted average shares · filed 2018-02-15 | $0.03 10-K · filed 2018-02-15 |
| 2015-09-30 | -$0.22 10-K · filed 2017-02-14 | -$0.16 derived: net income ÷ weighted average shares · filed 2017-02-14 | -$0.27 10-Q · filed 2016-11-01 | -$0.48 derived: net income ÷ weighted average shares · filed 2017-02-14 |
| 2015-06-30 | $0.05 10-K · filed 2017-02-14 | -$0.05 10-Q · filed 2016-08-09 | -$0.26 derived: net income ÷ weighted average shares · filed 2017-02-14 | $0.09 derived: net income ÷ weighted average shares · filed 2017-02-14 |
| 2015-03-31 | -$0.11 10-K · filed 2017-02-14 | -$0.32 derived: net income ÷ weighted average shares · filed 2017-02-14 | $0.04 derived: net income ÷ weighted average shares · filed 2017-02-14 | -$0.17 derived: net income ÷ weighted average shares · filed 2017-02-14 |
| 2014-12-31 | -$0.22 10-K · filed 2016-02-12 | $0.14 derived: net income ÷ weighted average shares · filed 2017-02-14 | -$0.07 derived: net income ÷ weighted average shares · filed 2017-02-14 | -$0.29 10-K · filed 2017-02-14 |
| 2014-09-30 | $0.33 10-K · filed 2016-02-12 | $0.14 derived: net income ÷ weighted average shares · filed 2016-02-12 | -$0.07 10-Q · filed 2015-11-03 | |
| 2014-06-30 | -$0.22 10-K · filed 2016-02-12 | -$0.43 10-Q · filed 2015-08-04 | ||
| 2014-03-31 | -$0.21 10-K · filed 2016-02-12 | |||
| 2013-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2016-02-12 | -$0.41 derived: net income ÷ weighted average shares · filed 2016-02-12 | -$0.56 10-K · filed 2016-02-12 | |
| 2013-09-30 | -$0.14 10-Q · filed 2014-10-30 | -$0.28 10-Q · filed 2014-10-30 | ||
| 2013-06-30 | -$0.02 10-Q · filed 2013-08-01 | -$0.13 10-Q · filed 2013-08-01 | ||
| 2012-12-31 | $0.14 10-K · filed 2014-02-21 | |||
| 2012-09-30 | -$0.17 10-K · filed 2014-02-21 | |||
| 2012-06-30 | $0.03 10-K · filed 2014-02-21 | -$0.32 10-Q · filed 2013-08-01 | ||
| 2012-03-31 | -$0.36 10-K · filed 2014-02-21 | |||
| 2011-06-30 | -$0.41 10-Q · filed 2012-08-03 | -$0.63 10-Q · filed 2012-08-03 | ||
| 2011-03-31 | -$0.21 10-Q · filed 2011-05-03 | |||
| 2010-12-31 | $0.24 10-K · filed 2012-02-22 | |||
| 2010-09-30 | -$0.26 10-K · filed 2012-02-22 | |||
| 2010-06-30 | $0.02 10-K · filed 2012-02-22 | -$0.27 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | -$0.30 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |